Evidence map›Paper›PMID 24965017›Full record

ArticleTransfusion2014

West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety.

Marion C Lanteri, Tzong-Hae Lee, Li Wen, Zhanna Kaidarova, Marjorie D Bravo, Nancy E Kiely, Hany T Kamel, Leslie H Tobler, Philip J Norris, Michael P Busch

Open access · greenAbstract read
In one paragraph

Article in Transfusion, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Observational
  15. Review
  16. Toscana, West Nile, Usutu and tick-borne encephalitis viruses: external quality assessment for molecular detection of emerging neurotropic viruses in Europe, 2017.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2019
    Article
  17. Article
  18. Article
  19. Optimizing PCR Detection of Zika Virus from Various Body Fluids.The American journal of tropical medicine and hygiene · 2019
    Article
  20. Tracking Rift Valley fever: From Mali to Europe and other countries, 2016.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Marion C LanteriBlood Systems Research Institute, San Francisco, California.
Tzong-Hae Lee
Li Wen
Zhanna Kaidarova
Marjorie D Bravo
Nancy E Kiely
Hany T Kamel
Leslie H Tobler
Philip J Norris
Michael P Busch
Blood Systems Research Institute · USVitalant · USUniversity of California, San Francisco · US

Funding

Viral/Immune parameters of Dengue and WNV in donors: blood safety implicationsRC2HL101632 · NHLBI · VITALANT · PI BUSCH, MICHAEL PAUL · 2009 to 2010
$2.1M
NHLBI NIH HHS RC2HL101NHLBI NIH HHS RC2 HL101632
6 · The paper itself

Abstract

backgroundPrevious reports of West Nile virus (WNV) RNA persistence in blood compartments have raised concerns around the remaining risk of WNV transfusion transmission. This study characterized the dynamics of WNV viremia in blood compartments in a longitudinal cohort of 54 WNV-infected blood donors. STUDY DESIGN AND

methodsBlood samples were collected throughout the year after WNV RNA-positive blood donation (index) and characterized for WNV immunoglobulin (Ig)M and IgG antibodies and for WNV RNA by real-time reverse transcription-polymerase chain reaction. WNV viral loads were compared in plasma and whole blood samples and correlated with blood groups and clinical outcomes.

resultsWNV RNA persisted in the red blood cell (RBC) compartment up to 3 months postindex in 42% of the donors. Donors with the highest WNV RNA levels in plasma at index maintained the highest WNV RNA levels in whole blood over the 3 months postindex. Blood group A donors maintained higher postindex WNV viral load in whole blood than blood group O individuals (p = 0.027). Despite a trend for WNV RNA to persist longer in whole blood from symptomatic subjects, no significant association was found between WNV RNA levels in whole blood and disease outcome.

conclusionThis study confirmed that WNV RNA persists in the RBC fraction in whole blood and further suggested that the level of persistence in whole blood may be a reflection of initial viral burden in plasma. The association with blood groups suggests that WNV adherence to RBCs may be mediated by molecules overrepresented at the surface of blood group A RBCs.

Indexed as

Blood DonorsSafetyWest Nile virusABO Blood-Group SystemAntibodies, ViralFemaleHumansImmunoglobulin GImmunoglobulin MLongitudinal StudiesMaleMiddle AgedRNA, ViralViral LoadWest Nile FeverABO Blood-Group SystemAntibodies, ViralImmunoglobulin GImmunoglobulin MRNA, Viral

Identifiers

PMID24965017
PMCPMC4268370
OpenAlexW2158555963

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.